| Literature DB >> 32294990 |
Yael Yagel1, Stephanie Sestito1, Yair Motro1, Anat Shnaiderman-Torban2, Boris Khalfin1, Orly Sagi3, Shiri Navon-Venezia4, Amir Steinman2, Jacob Moran-Gilad1.
Abstract
Ochrobactrum is a ubiquitous Gram-negative microorganism, mostly found in the environment, which can cause opportunistic infections in humans. It is almost uniformly resistant to penicillins and cephalosporins through an AmpC-like β-lactamase enzyme class (OCH). We studied 130 assembled genomes, of which 5 were animal-derived isolates recovered in Israel, and 125 publicly available genomes. Our analysis focused on antimicrobial resistance (AMR) genes, virulence genes, and whole-genome phylogeny. We found that 76% of Ochrobactrum genomes harbored a blaOCH β-lactamase gene variant, while 7% harbored another AmpC-like gene. No virulence genes other than lipopolysaccharide-associated genes were found. Core genome multilocus sequence typing clustered most samples to known species, but neither geographical clustering nor isolation source clustering were evident. When analyzing the distribution of different blaOCH variants as well as of the blaOCH-deficient samples, a clear phylogenomic clustering was apparent for specific species. The current analysis of the largest collection to date of Ochrobactrum genomes sheds light on the resistome, virulome, phylogeny, and species classification of this increasingly reported human pathogen. Our findings also suggest that Ochrobactrum deserves further characterization to underpin its evolution, taxonomy, and antimicrobial resistance.Entities:
Keywords: antimicrobial resistance; phylogeny; veterinary; whole-genome sequencing; β-lactamase
Year: 2020 PMID: 32294990 PMCID: PMC7235858 DOI: 10.3390/antibiotics9040177
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Features of the five new Ochrobactrum isolates recovered and sequenced in this study.
| Isolate No. | OCH-ISR1 | OCH-ISR2 | OCH-ISR3 | OCH-ISR4 | OCH-ISR5 |
|---|---|---|---|---|---|
| MALDI TOF MS identification—Best match |
|
|
|
|
|
| Origin | Horse, on admission to veterinary hospital | Horse, on admission to veterinary hospital | Healthy horse 1, community collection | Healthy horse 1, community collection | Fat sand rat ( |
| Comments | 12-year-old gelding, gastrointestinal pathology | 1-month-old filly, respiratory pathology | 16-year-old healthy mare, gut colonization | 9-year-old healthy mare, gut colonization | − |
|
| |||||
| Total reads | 1,984,624 | 1,137,438 | 925,646 | 1,497,780 | 1,693,904 |
| Total bases | 276,000,000 | 160,000,000 | 131,000,000 | 203,000,000 | 241,000,000 |
| % GC | 57.4 | 55.6 | 57.2 | 57 | 57.3 |
| Minimum read length | 35 | 35 | 35 | 35 | 35 |
| Average read length | 139 | 140 | 141 | 135 | 142 |
| Maximum read length | 151 | 151 | 151 | 151 | 151 |
| Mode read length | 151 | 151 | 151 | 151 | 151 |
| Average quality 2 | 35.5 | 35.3 | 35 | 34.9 | 35.6 |
| Calculating depth | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| Sequencing depth of coverage 3 | 55x | 31x | 26x | 40x | 48x |
| Number of contigs | 53 | 115 | 171 | 71 | 52 |
| Total Base Pairs | 3,813,327 | 4,758,714 | 4,270,779 | 4,807,944 | 4,904,698 |
| Minimum | 2.05 × 102 | 2.00 × 102 | 2.01 × 102 | 200 | 2.03 × 102 |
| Average | 86,928 | 41,380 | 249,75 | 67,717 | 94321 |
| Maximum | 912,538 | 500,181 | 476,636 | 874,803 | 830,669 |
| N50 | 427,705 | 308,273 | 240,761 | 363,912 | 397,644 |
1 Farm horse; 2 Phred quality score; 3 According to 5 Mb reference.
Phenotypic resistance of Ochrobactrum (five unpublished isolates and pooled published data). MIC, minimal inhibitory concentration.
|
| Measured MIC Values (µg/mL) | Reported MIC Values (µg/mL) | |||||
|---|---|---|---|---|---|---|---|
| OCH-ISR1 | OCH-ISR2 | OCH-ISR3 | OCH-ISR4 | OCH-ISR5 |
|
| |
| Ampicillin | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | 256, (32–256) | 101 |
| Ampicillin–Sulbactam | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | 32, (32–32) | 5 |
| Amoxicillin–Clavulanic Acid | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | 256, (32–256) | 101 |
| Ticaricillin | ≥128 | ≥128 | ≥64 | ≥128 | ≥128 | 128, (64–128) | 12 |
| Piperacillin | ≥128 | ≥128 | ≥128 | ≥128 | ≥128 | 256, (128–256) | 101 |
| Piperacillin–tazobactam | ≥128 | ≥128 | ≥128 | ≥128 | ≥1228 | 128, (16–256) | 22 |
| Cefalexin | ≥64 | ≥64 | ≥64 | ≥64 | ≥64 | 64, (64–64) | 5 |
| Cefuroxime | ≥64 | ≥64 | ≥64 | ≥64 | ≥64 | 64, (32–128) | 19 |
| Cefoxitin | ≥64 | ≥64 | ≥64 | ≥64 | ≥64 | 96, (64–128) | 12 |
| Ceftazidime | ≥64 | ≥64 | ≥64 | ≥64 | ≥64 | 256, (8–256) | 111 |
| Ceftriaxone | ≥64 | ≥64 | ≥64 | ≥64 | ≥64 | 256, (4–256) | 93 |
| Ertapenem | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | 0.25, (0.064–0.5) | 12 |
| Imipenem | 1 | 0.5 | 0.5 | 1 | 1 | 2, (0.128–256) | 114 |
| Meropenem | 1 | 0.5 | 0.5 | 1 | 1 | 0.5, (0.128–16) | 21 |
| Amikacin | ≥64 | 4 | 16 | 16 | ≥64 | 3, (1–64) | 12 |
| Gentamicin | 8 | ≤1 | ≤1 | 8 | 8 | 4, (0.256–256) | 104 |
| Tobramycin | ≥16 | ≤1 | ≤1 | ≥16 | ≥16 | 16, (1–16) | 5 |
| Ciprofloxacin | ≤0.25 | ≤0.25 | 0.5 | ≤0.25 | ≤0.25 | 0.25, (0.25–0.5) | 12 |
| Levofloxacin | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25, (0.25–0.25) | 5 |
| Minocycline | ≤1 | ≤1 | ≤1 | ≤1 | ≤1 | 1, (1–1) | 5 |
| Tigecycline | 4 | 2 | 1 | 4 | 4 | 2, (0.28–4) | 12 |
| Fosfomycin | ≥256 | ≥256 | ≥256 | ≥256 | ≥256 | 256, (256–256) | 5 |
| Nitrofurantoin | 256 | 256 | 256 | 256 | 256 | 256, (256–256) | 5 |
| Trimethoprim/ sulfamethoxazole (TMP–SMX) | ≤20 | ≤20 | ≤20 | ≤20 | ≤20 | 0.064, (0.064–256) | 104 |
Resistome analysis among Ochrobactrum genomes (n = 130). AMR, antimicrobial resistance.
| Gene Name | AMR Gene Family | Drug Target | Resistance Mechanism | % of Total Sequences (n = 130) |
|---|---|---|---|---|
| β | ||||
| OCH-1 | OCH β-lactamase | Cephalosporin, cephamycin, monobactam | Antibiotic inactivation | 7.7 (10) |
| OCH-2 | 27.7 (36) | |||
| OCH-3 | 4.6 (6) | |||
| OCH-4 | 6.2 (8) | |||
| OCH-5 | 4.6 (6) | |||
| OCH-6 | 7 (9) | |||
| OCH-7 | 13.1 (17) | |||
| OCH-8 | 5.4 (7) | |||
| Any OCH | 76.2 (99) | |||
| AmpC | AmpC-type β-lactamase | Cephalosporin, penicillin | − | 7 1 (9) |
| Any β-lactamase | − | − | − | 83.1 (108) |
|
| ||||
|
| Resistance-nodulation-cell division (RND) efflux pump system and related genes | Triclosan | Antibiotic efflux complex | 97.7 (127) |
|
| Aminoglycosides, fluoroquinolones | 96.2 (125) | ||
|
| Phenicol antibiotics, β-lactams | 42.3 (55) | ||
| Aminoglycoside-modifying enzymes | Aminoglycosides | Antibiotic inactivation | 10.8 2 (14) | |
1 80% homology to an existing gene in Comprehensive Antibiotic Resistance Database (CARD) database. 2 Percentage of samples which had at least one of the following aminoglycoside-modifying enzyme genes: aac(3)-IIc, aac(3)-IId, aac(6’)-Ib7, aac(6’)-Il, ant(2’’)-Ia, ant(3’’)-IIa, aph(3’’)-Ib, aph(3’)-Ib, aph(4)-Ia, aph(6)-Id.
Figure 1Arrangement of the genes surrounding the OCH β-lactamase and its regulator (LysR family). Dashed lines illustrate the genes that are absent in OCH-deficient samples (in red), with all other genes present (in blue).
Virulome analysis among Ochrobactrum genomes (n = 130).
| Gene Name | Protein | Function | % of Human Isolates (n = 22) | % of Other Isolates (n = 82) | % of Total Isolates (n = 130) |
|---|---|---|---|---|---|
|
| |||||
|
| Acyl carrier protein | Lipid A biosynthesis | 100 (22) | 100 (82) | 100 (130) |
|
| Lauroyltransferase | 100 (22) | 98 (80) | 98 (127) | |
| Multiple | 100 1 (22) | 1001 (82) | 99 1 (129) | ||
|
| Acyl carrier protein | Fatty acid biosynthesis | 100 (22) | 98 (80) | 98 (127) |
|
| Phosphoglucomutase-1 | Carbohydrate metabolism | 95 (21) | 98 (80) | 97 (126) |
|
| Glucan synthesis | 95 (21) | 96 (79) | 95 (123) | |
|
| Glucosyltransferase | Cell wall synthesis and organization | 100 (22) | 96 (79) | 96 (125) |
|
| Regulator protein | Biofilm formation | 100 (22) | 93 (76) | 95 (123) |
|
| Chaperone | Folding, adhesion, invasion factor | 36 (8) | 48 (39) | 40 (52) |
| Multiple | Polysaccharide synthesis | 92 (2) | 8.52 (7) | 9.22 (12) | |
|
| Glycosyltransferase | 9 (2) | 8.5 (7) | 9.2 (12) | |
|
| Magnesium-transporting ATPase | Mediates magnesium influx | 4.5 (1) | 3.7 (3) | 4.6 (6) |
|
| Urease subunit | Urea degradation | 4.5 (1) | 2.4 (2) | 2 (3) |
1 Percentage of samples which contained at least one of the following: ipxA, ipxB, ipxC, ipxD, or ipxE. 2 Percentage of samples which possessed manA and manB (no samples possessed only one variant).
Figure 2Minimum spanning tree (MST) showing ad hoc core genome multilocus sequence typing (cgMLST) analysis (1726 loci). Node color indicates species assignment using average nucleotide identity (ANI). Reference strains are denoted by an outer red ring. White nodes represent samples unassigned to any reference species.
Figure 3MST showing ad hoc cgMLST analysis (1726 loci). Node color indicates the source of isolation. Reference strains are denoted by an outer red ring.
Figure 4MST showing ad hoc cgMLST analysis (1726 loci). Node color indicates the geographic origin. Reference strains are denoted by an outer red ring.
Figure 5Neighbor-joining (NJ) phylogenetic tree presenting the species assignment according to ANI (node colors) and the distribution of OCH genes across species and phylogeny.